A safety study of combination treatment with Avonex [interferon beta-1a] and placebo-controlled dosing of Topamax [topiramate] in relapsing-remitting multiple sclerosis
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Interferon beta-1a (Primary) ; Topiramate (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 10 Nov 2005 New trial record.